186 related articles for article (PubMed ID: 8167950)
1. The efficacy of various classes of anti-emetics in preventing deoxynivalenol-induced vomiting in swine.
Prelusky DB; Trenholm HL
Nat Toxins; 1993; 1(5):296-302. PubMed ID: 8167950
[TBL] [Abstract][Full Text] [Related]
2. Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin).
Wu W; Bates MA; Bursian SJ; Flannery B; Zhou HR; Link JE; Zhang H; Pestka JJ
Toxicol Sci; 2013 May; 133(1):186-95. PubMed ID: 23457120
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological agents affecting emesis. A review (Part I).
Mitchelson F
Drugs; 1992 Mar; 43(3):295-315. PubMed ID: 1374316
[TBL] [Abstract][Full Text] [Related]
4. A dual effect of some 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon.
Navarra P; Martire M; del Carmine R; Pozzoli G; Preziosi P
Toxicol Lett; 1992 Dec; 64-65 Spec No():745-9. PubMed ID: 1471230
[TBL] [Abstract][Full Text] [Related]
5. Calcium-Sensing Receptor and Transient Receptor Ankyrin-1 Mediate Emesis Induction by Deoxynivalenol (Vomitoxin).
Wu W; Zhou HR; Bursian SJ; Link JE; Pestka JJ
Toxicol Sci; 2017 Jan; 155(1):32-42. PubMed ID: 27667315
[TBL] [Abstract][Full Text] [Related]
6. Effects of lerisetron, a new 5-HT3 receptor antagonist, on ipecacuanha-induced emesis in healthy volunteers.
Cooper M; Sologuren A; Valiente R; Smith J
Arzneimittelforschung; 2002; 52(9):689-94. PubMed ID: 12404884
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy induced emesis: pathophysiology and prevention].
Mailliez A; Bonneterre J
Bull Cancer; 2010 Feb; 97(2):233-43. PubMed ID: 20051348
[TBL] [Abstract][Full Text] [Related]
8. Type A Trichothecene Diacetoxyscirpenol-Induced Emesis Corresponds to Secretion of Peptide YY and Serotonin in Mink.
Wu Q; Kuca K; Nepovimova E; Wu W
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32630472
[TBL] [Abstract][Full Text] [Related]
9. An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting.
Jantunen IT; Kataja VV; Muhonen TT
Eur J Cancer; 1997 Jan; 33(1):66-74. PubMed ID: 9071902
[TBL] [Abstract][Full Text] [Related]
10. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
[TBL] [Abstract][Full Text] [Related]
11. Emetic activity of the trichothecene 15-acetyldeoxynivalenol in swine.
Pestka JJ; Lin WS; Miller ER
Food Chem Toxicol; 1987 Nov; 25(11):855-8. PubMed ID: 3692388
[TBL] [Abstract][Full Text] [Related]
12. Comparison of anorectic and emetic potencies of deoxynivalenol (vomitoxin) to the plant metabolite deoxynivalenol-3-glucoside and synthetic deoxynivalenol derivatives EN139528 and EN139544.
Wu W; Zhou HR; Bursian SJ; Pan X; Link JE; Berthiller F; Adam G; Krantis A; Durst T; Pestka JJ
Toxicol Sci; 2014 Nov; 142(1):167-81. PubMed ID: 25173790
[TBL] [Abstract][Full Text] [Related]
13. Anti-emetic therapy in cancer chemotherapy: current status.
Herrstedt J; Dombernowsky P
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
[TBL] [Abstract][Full Text] [Related]
14. Emesis to trichothecene deoxynivalenol and its congeners correspond to secretion of peptide YY and 5-HT.
Wei B; Xiao H; Xu B; Kuca K; Qin Z; Guo X; Wu W; Wu Q
Food Chem Toxicol; 2023 Aug; 178():113874. PubMed ID: 37286030
[TBL] [Abstract][Full Text] [Related]
15. 5HT3-antagonist receptors: their role in drug-induced emesis.
Dieras V; Extra JM; Le Bonniec M; Madelaine I; Espie M; Marty M
Nouv Rev Fr Hematol (1978); 1990; 32(6):449-52. PubMed ID: 1983228
[TBL] [Abstract][Full Text] [Related]
16. The trichothecene neosolaniol stimulates an emetic response through neuropeptide Y2 and serotonin 3 receptors in mink.
Wu Q; Guo D; Jia H; Nepovimova E; Wu W; Kuca K
Toxicology; 2021 Mar; 452():152718. PubMed ID: 33581213
[TBL] [Abstract][Full Text] [Related]
17. Glucose-Dependent Insulinotropic Polypeptide and Substance P Mediate Emetic Response Induction by Masked Trichothecene Deoxynivalenol-3-Glucoside through Ca
Qin Z; Zhang H; Wu Q; Wei B; Wu R; Guo X; Xiao H; Wu W
Toxins (Basel); 2022 May; 14(6):. PubMed ID: 35737032
[TBL] [Abstract][Full Text] [Related]
18. Update on anti-emetics for chemotherapy-induced emesis.
Olver IN
Intern Med J; 2005 Aug; 35(8):478-81. PubMed ID: 16176471
[TBL] [Abstract][Full Text] [Related]
19. Controlling cancer chemotherapy-induced emesis. An update.
Seynaeve C; De Mulder PH; Verweij J; Gralla RJ
Pharm Weekbl Sci; 1991 Oct; 13(5):189-97. PubMed ID: 1749707
[TBL] [Abstract][Full Text] [Related]
20. Advances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimens.
Grunberg SM
Blood Rev; 1989 Dec; 3(4):216-21. PubMed ID: 2692744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
